← Open Payments lookup

KELLY EGUCHI: Open Payments

NPI 1013453612 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,189 in 134 payments from 15 companies in 2025. Trend: 2023 $2,029 · 2024 $2,786 · 2025 $3,189

Food & beverage: $3,189
CompanyPaymentsAmount
ABBVIE INC.32$786
Neurocrine BioSciences, Inc.18$563
Lundbeck LLC18$387
Vanda Pharmaceuticals Inc.16$331
Axsome Therapeutics, Inc.9$246
Noven Therapeutics, LLC10$175
Otsuka America Pharmaceutical, Inc.7$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$151
Teva Pharmaceuticals USA, Inc.5$112
Janssen Pharmaceuticals, Inc3$69

Products named: VRAYLAR, INGREZZA, REXULTI, FANAPT, Auvelity, Xelstrym, CAPLYTA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.